Novozymes Total Liabilities and Share Holders Equity 2011-2024 | NVZMY

Novozymes total liabilities and share holders equity for the quarter ending June 30, 2024 was $4.122B, a 4.04% increase year-over-year.

  • Novozymes total liabilities and share holders equity for 2024 was $16.443B, a 298.88% increase from 2023.
  • Novozymes total liabilities and share holders equity for 2023 was $4.122B, a 4.04% increase from 2022.
  • Novozymes total liabilities and share holders equity for 2022 was $3.962B, a 0.56% increase from 2021.

Novozymes Total Liabilities and Share Holders Equity 2011-2024 | NVZMY

  • Novozymes total liabilities and share holders equity for 2024 was $16.443B, a 298.88% increase from 2023.
  • Novozymes total liabilities and share holders equity for 2023 was $4.122B, a 4.04% increase from 2022.
  • Novozymes total liabilities and share holders equity for 2022 was $3.962B, a 0.56% increase from 2021.